For further information on how we select topics for development, please see our page about topic selection ...

Xofluza (baloxavir marboxil) is already approved to treat people infected with flu, but the new results make a case to extend its use to include healthy people at risk of contracting the virus ...

The label for Xofluza (baloxavir marboxil) has been extended to include the treatment of uncomplicated flu infections in children aged one year and over, a particularly vulnerable group of ...

Potent Preclinical Suppression of Resistant Virus: Laboratory studies showed that TXM potently suppressed influenza A, B and C viruses and baloxavir resistant flu viruses, with sub-nanomolar ...

Poster Title: Tivoxavir marboxil, an Influenza Inhibitor Targeting ... B and C viruses and baloxavir resistant flu viruses, with sub-nanomolar potency against H5N1/influenza A virus.

Poster underscores Tivoxavir Marboxil’s potential for the treatment of bird flu, supported by 100% survival in a rodent ...

Tivoxavir Marboxil Poster Data in the poster support ... B and C viruses and baloxavir resistant flu viruses, with sub-nanomolar potency against H5N1/influenza A virus. Potent Antiviral Activity ...